Sjögren Syndrome

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 401-416

  Manoussakis, Menelaos N ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548298979     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50034-2     Document Type: Chapter

References (119)

1. R.F. Abu-Helu, I.D. Dimitriou, E.K. Kapsogeorgou, H.M. Moutsopoulos and M.N. Manoussakis (2001) Induction of salivary gland epithelial cell injury in Sjögren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. J. Autoimmun. 17 141-153.
2. B.K. Adams, H.M. Al Attia and S. Parkar (2003) Salivary gland scintigraphy in Sjögren's syndrome: are quantitative indices the answer? Nucl. Med. Commun. 24 1011-1016.
3. R.A. Ajjan, R.S. McIntosh, E.A. Waterman, P.F. Watson, C.D. Franklin, C.M. Yeoman and A.P. Weetman (1998) Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome. Br. J. Rheumatol. 37 179-185.
4. E.I. Alexander (1987) Inflammatory vascular disease in Sjögren's syndrome. N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's Syndrome: Clinical and Immunological Aspects Berlin: Springer-Verlag 102-125.
5. E.L. Alexander, M.R. Ranzenbach, A.J. Kumar, W.E. Kozachuk, A.E. Rosenhaum, N. Patronas, J.B. Harley and M. Reichlin (1994) Anti-Ro(SSA) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS SS): Clinical, neuroimaging, and angiographic correlates. Neurology 44 899-908.
6. S. Alpert, H.I. Kang, I. Weissman and R.I. Fox (1994) Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. Arthritis Rheum. 37 1046-1054.
7. N. Amft, S.J. Curnow, D. Scheel-Toellner, A. Devadas, J. Oates, J. Crocker, J. Hamburger, J. Ainsworth, J. Mathews, M. Salmon, S.J. Bowman and C.D. Buckley (2001) Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum. 44 2633-2641.
8. K.E. Aziz, P.J. McCluskey and D. Wakefield (1996) Expression of selectins (CD62 E,L,P) and cellular adhesion molecules in primary Sjögren's syndrome. Clin. Immunol. Immunopathol. 80 55-66.
9. M. Bachmann, K. Pfeifer, H.C. Schroder and W.E.G. Muller (1990) Characterization of the autoantigen La as a nucleic acid-dependent ATPase/ATPase with melting properties. Cell 60 85-93.
10. S. Bacman, C. Perez Leiros, L. Sterin-Borda, O. Hubscher, R. Arana and E. Borda (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci. 39 151-156.
11. S. Boiu-Zahiu, E.K. Kapsogeorgou, I.D. Dimitriou, M.P. Spahidou, H.M. Moutsopoulos and M.N. Manoussakis (2004) Elevated expression of IL-18 in Sjögren's syndrome: distinct expression patterns of the active and proactive forms. Arthritis Res. Ther. 6(Suppl 1), S8.
12. A.I. Bolstad, R. Wassmuth, H.J. Haga and R. Jonsson (2001) HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome. J. Rheumatol. 28 1554-1562.
13. A.I. Bolstad, H.G. Eiken, B. Rosenlund, M.E. Alarcon-Riquelme and R. Jonsson (2003) Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome. Arthritis Rheum. 48 174-185.
14. O. Boulard, G. Fluteau, L. Eloy, D. Damotte, P. Bedossa and H.J. Garchon (2002) Genetic analysis of autoimmune sieladenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J. Immunol 168 4192-4199.
15. D. Boumba, F.N. Skopouli and H.M. Moutsopoulos (1995) Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br. J. Rheumatol. 34 326-333.
16. J. Brayer, J. Lowry, S. Cha, C.P. Robinson, S. Yamachika, A.B. Peck and M.G. Humphreys-Beher (2000) Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy. J. Rheumatol. 27 1896-1901.
17. A. Cauli, G. Yanni, C. Pitzalis, S. Challacombe and G.S. Panayi (1995) Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis. Ann. Rheum. Dis. 54 209-215.
18. S. Cha, S.C. van Blockland, M.A. Versnel, F. Homo-Delarche, H. Nagashima, J. Brayer, A.B. Peck and M.G. Humphreys-Beher (2001) Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp. Clin. Immunogenet. 18 143-146.
19. S. Cha, H. Nagashima, V.B. Brown, A.B. Peck and M.G. Humphreys-Beher (2002) Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum. 46 1390-1398.
20. D.M. Chisholm and D.K. Mason (1968) Labial salivary gland biopsy in Sjögren's syndrome. J. Clin. Pathol. 21 656-660.
21. C. Cuello, P. Palladinetti, N. Tedla, N. Di Girolamo, A.R. Lloyd, P.J. McCluskey and D. Wakefield (1998) Chemokine expression and leucocyte infiltration in Sjögren's syndrome. Br. J. Rheumatol. 37 779-783.
22. M.J. Cummins, A. Papas, G.M. Kammer and P.C. Fox (2003) Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum. 49 585-593.
23. U.G. Dafni, A.G. Tzioufas, P. Staikos, F.N. Skopouli and H.M. Moutsopoulos (1997) Prevalence of Sjögren's syndrome in a closed rural community. Ann. Rheum. Dis. 56 521-525.
24. T.E. Daniels, T.B. Aufdemorte and J.S. Greenspan (1987) Histopathology of Sjögren's syndrome. N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's Syndrome: Clinical and Immunological Aspects Berlin: Springer-Verlag 41-52.
25. I.D. Dimitriou, E.K. Kapsogeorgou, H.M. Moutsopoulos and M.N. Manoussakis (2002) CD40 on salivary gland epithelial cells: High constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation. Clin. Exp. Immunol. 127 386-392.
26. I.D. Dimitriou, E.K. Kapsogeorgou, R.F. Abu-Helu, H.M. Moutsopoulos and M.N. Manoussakis (2002) Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur. J. Oral Sci. 110 21-30.
27. T. Dorner, A. Hansen, A. Jacobi and P.E. Lipsky (2002) Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome. Autoimmun. Rev. 1 119-124.
28. A.A. Drosos, A.P. Antonopoulos, J.S. Costopoulos, C. Papadimitriou and H.M. Moutsopoulos (1988) Prevalence of primary Sjögren's syndrome in an elderly population. Br. J. Rheumatol. 27 123-127.
29. A.A. Drosos, S.H. Constantopoulos, D. Phsychos, D. Stefanou, C.S. Papadimitriou and H.M. Moutsopoulos (1989) The forgotten cause of sicca complex; sarcoidosis. J. Rheumatol. 16 1548-1551.
30. A.A. Drosos, Y.L. Pennec, M. Elisaf, N.C. Acritidis, J. Jouquan, H.M. Moutsopoulos and P. Youinou (1991) Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma. J. Rheumatol. 18 1685-1688.
31. M. Fleck, H.G. Zhang, E.R. Kern, H.C. Hsu, U. Muller-Ladner and J.D. Mountz (2001) Treatment of chronic sialadenitis in murine model of Sjögren's syndrome by local FasL gene transfer. Arthritis Rheum. 44 964-973.
32. R.I. Fox, H.I. Kang, D. Ando, J. Abrams and E. Pisa (1994) Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J. Immunol. 152 5532-5539.
33. B. Freimark, R. Fantozzi, R. Bone, G. Bordin and R. Fox (1989) Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome. Arthritis Rheum. 32 859-869.
34. T. Fujihara, H. Fujita, K. Tsubota, K. Saito, K. Tsuzaka, T. Abe and T. Takeuchi (1999) Preferential localization of CD8+alpha E beta 7+T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J Immunol. 163 2226-2235.
35. G. Gannot, H.E. Lancaster and P.C. Fox (2000) Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects. J. Rheumatol. 27 1905-1909.
36. R.F. Garry, C.D. Fermin, D.J. Hart, S.S. Alexander, L.A. Donehower and H. Luo-Zhang (1990) Detection of a human intracisternal A type retroviral particle antigenically related to HIV. Science 250 1127-1130.
37. J.E. Gottenberg, M. Busson, P. Loiseau, J. Cohen-Solal, V. Lepage, D. Charron, J. Sibilia and X. Mariette (2003) In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 48 2240-2245.
38. J.E. Gottenberg, M. Busson, P. Loiseau, M. Dourche, J. Cohen-Solal, V. Lepage, D. Charron, C. Miceli, J. Sibilia and X. Mariette (2004) Association of transforming growth factor betal and tumor necrosis factor alpha polymorphisms with anti SSB/La antibody secretion in patients with primary Sjögren's syndrome. Arthritis Rheum. 50 570-580.
39. A. Goules, S. Masouridi, A.G. Tzioufas, et al. (2000) Clinically significant and biopsy-documented renal involvement in primary Sjögren's syndrome. Medicine (Baltimore) 79 241-249.
40. J.S. Greenspan, T.E. Daniels, N. Talal and R.A. Sylvester (1974) The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg. Oral Med. Oral Pathol. 37 217-229.
41. J. Groom, S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, P. Schneider, J. Tschopp, T.G. Cachero, M. Batten, J. Wheway, D. Mauri, D. Cavill, T.P. Gordon, C.R. Mackay and F. Mackay (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109 59-68.
42. J. Haddad, P. Deny, C. MunzGothiel, J.C. Amhrosini, J.C. Trinchet, D. Pateron, F. Mal, P. Gallard and M. Beaugrad (1992) Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339 321-323.
43. N. Haneji, H. Hamano, K. Yanagi and Y. Hayashi (1994) A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice. J. Immunol. 153 2769-2777.
44. N. Haneji, T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino and Y. Nayashi (1997) Identification of alpha-fodrin as a candidate antoantigen in primary Sjögren's syndrome. Science 276 604-607.
45. J.B. Harley (1987) Autoantibodies in Sjögren's syndrome. N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's Syndrome: Clinical and Immunological Aspects Berlin: Springer-Verlag 218-234.
46. J.B. Harley, M. Reichlin, F.C. Arnett, E.L. Alexander, W.B. Bias and T.T. Provost (1986) Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 232 1145-1147.
47. R.W. Hoffman and S.E. Walker (1987) Animal models of Sjögren's syndrome. N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's Syndrome: Clinical and Immunological Aspects Berlin: Springer-Verlag 266-288.
48. Y. Ichikawa, K. Arimori, M. Yoshida, et al. (1995) Abnormal expression of apoptosis-related antigens. Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome. Clin. Exp. Rheumatol. 13 307-313.
49. S. Itescu (1991) Diffuse infiltrative lymphocytosis syndrome in human immunodeficiency virus infection — a Sjögren's-like disease. Rheum. Dis. Clin. N. Am. 17 99-115.
50. J.P. Ioannidis, V.A. Vassiliou and H.M. Moutsopoulos (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum. 46 741-747.
51. L.T.H. Jacobsson, T.E. Axell, B.U. Hansen, V.J. Henriesson, A. Larsson, K. Lieberkind, B. Lilja and R. Manthrope (1989) Dry eyes or mouth. An epidemiological study in Swedish adults with special reference to primary Sjögren's syndrome. J. Autoimmun. 2 521-527.
52. F. Jimenez, S. Aiba-Masago, I. Al Hashimi, N. Vela-Roch, G. Fernandes, C.K. Yeh, N. Talal and H. Dang (2002) Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndrome. Rheumatology 41 338-342.
53. E.O. Johnson and H.M. Moutsopoulos (1992) Neuroimmunological axis and rheumatic diseases, (editorial). Eur. J. Clin. Invest. 22 25.
54. E.K. Kapsogeorgou, I.D. Dimitriou, R.F. Abu-Helu, H.M. Moutsopoulos and M.N. Manoussakis (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin. Exp. Immunol. 124 126-133.
55. E.K. Kapsogeorgou, H.M. Moutsopoulos and M.N. Manoussakis (2001) Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J. Immunol. 166 3107-3113.
56. E.K. Kapsogeorgou, I.D. Dimitriou, R.F. Abu-Helu, H.M. Moutsopoulos and M.N. Manoussakis (2003) Cultured salivary gland epithelial cells release exosomes that contain the Sjögren's syndrome-associated autoantigenic ribonucleoproteins Ro/SSA and La/SSB. Arthritis Res. Ther. 5(Suppl 1), S4.
57. S.S. Kassan, T. Thomas, H.M. Moutsopoulos, R. Hoover, R.P. Kimberly, D.R. Budman, J. Costa, J.L. Decker and T.M. Chused (1978) Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 89 888-892.
58. M. Kauppi, E. Pukkala and H. Isomaki (1997) Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 8 201-204.
59. M.C. Kincaid (1987) The eye in Sjögren's syndrome. N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's syndrome: Clinical and Immunological Aspects Berlin: Springer-Verlag 25-34.
60. L. Kong, N. Ogawa, T. Nakabayashi, G.T. Liu, E. D'Souza, H.S. McGuff, D. Guerrero, N. Talal and H. Dang (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 40 87-97.
61. H. Koski, A. Janin, M.G. Humphreys-Beher, T. Sorsa, M. Malmstrom and Y.T. Konttinen (2001) Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome. Clin. Exp. Rheumatol. 19 131-137.
62. G. Lindahl, E. Hedfors, L. Klareskog and U. Forsum (1985) Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin. Exp. Immunol. 61 475-482.
63. S.J. Manavalan, J.R. Valiando, W.H. Reeves, F.C. Arnett, A. Necker, R. Simantov, R. Lyons, M. Satoh and D.N. Posnett (2004) Genomic absence of the gene encoding T cell receptor Vbeta7.2 is linked to the presence of autoantibodies in Sjögren's syndrome. Arthritis Rheum. 50 187-198.
64. M.N. Manoussakis, I.D. Dimitriou, E.K. Kapsogeorgou, G. Xanthou, S. Paikos, M. Polihronis and H.M. Moutsopoulos (1999) Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum. 42 229-239.
65. M.N. Manoussakis, C. Georgopoulou, E. Zintzaras, M. Spyropoulou, A. Stavropoulou, F.N. Skopouli and H.M. Moutsopoulos (2004) Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum. 50 882-891.
66. X. Mariette, P. Ravaud, P. Steinfeld, G. Baron, J. Goetz, E. Hachulla, B. Combe, X. Puechal, Y. Pennec, B. Sauvezie, A. Perdriger, G. Hayem, A. Janin and J. Sibilia (2004) Inefficacy of Infliximab in primary Sjögren's syndrome, results of the Randomized, Controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum. 50 1270-1276.
67. P.B. Martens, S.R. Pillemer, L.T. Jacobsson, W.M. O'Fallon and E.L. Matteson (1999) Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976–1992. J. Rheumatol. 26 1296-1300.
68. I. Matsumoto, K. Tsubota, Y. Satake, Y. Kita, R. Matsumura, H. Murata, T. Namekawa, K. Nishioka, I. Iwamoto, Y. Saitoh, T. Sumida and P.J. Dyck (1996) Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J. Clin. Invest. 97 1969-1977.
69. T.A. Medsger Jr. (1987) Sjögren's syndrome and systemic sclerosis (scleroderma). N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's Syndrome: Clinical and Immunological Aspects Berlin: Springer-Verlag 182-187.
70. H.M. Moutsopoulos (1994) Sjögren's syndrome: Autoimmune epithelitis. Clin. Immunol. Immunopathol. 72 162-165.
71. H.M. Moutsopoulos, Webber, T.P. Vlagopoulos, T.M. Chused and J.L. Decker (1979) Differences in the clinical presentation of sicca syndrome in the presence and in the absence of rheumatoid arthritis. Am. J. Med. 66 733-736.
72. H.M. Moutsopoulos, T.M. Chused, D.L. Mann, J.H. Klippel, A.S. Fauci, M.M. Frank, T.J. Lawley and M.I. Hamburger (1980) Sjögren's syndrome (sicca syndrome): Current issues. Am. Intern. Med. 92 212-226.
73. R.K. Niemela, R. Takalo, E. Paakko, I. Suramo, M. Paivansalo, T. Salo and M. Hakala (2004) Ultrasonography of salivary glands in primary Sjögren's syndrome. A comparison with magnetic resonance imaging and magnetic resonance sialography of parotid glands. Rheumatology 41 338-342.
74. N. Ogawa, H. Dang, L. Kong, J.M. Anaya, G.T. Liu and N. Talal (1996) Lymphocyte apoptosis and apoptosis-associated gene expression in Sjögren's syndrome. Arthritis Rheum. 39 1875-1885.
75. N. Ogawa, L. Ping, L. Zhenjun, Y. Takada and S. Sugai (2002) Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum. 46 2730-2741.
76. M. Ohlsson, K. Skarstein, A.I. Bolstad, A.C. Johannessen and R. Jonsson (2001) Fas-induced apoptosis is a rare event in Sjögren's syndrome. Lab. Invest. 81 95-105.
77. M. Ohlsson, R. Jonsson and K.A. Brokstad (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand. J. Immunol. 56 456-469.
78. Y. Ohyama, S. Nakamura, G. Matsuzaki, M. Shinohara, A. Hiroki, T. Fujimura, A. Yamada, K. Itoh and K. Nomoto (1996) Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 39 1376-1384.
79. P. Oxholm, T.E. Daniels and K. Bendtzen (1992) Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. Autoimmunity 12 185-191.
80. T. Paisansinsup, U.S. Deshmukh, V.R. Chowdhary, H.S. Luthra, S.M. Fu and C.S. David (2002) HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J. Immunol. 168 5876-5884.
81. D. Petrone, J.J. Condemi, R. Fife, O. Gluck, S. Cohen and P. Dalgin (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 46 748-754.
82. M. Pertovaara, E. Pukkala, P. Laippala, A. Miettinen and A. Pasternack (2001) A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann. Rheum. Dis. 60 467-472.
83. E.H. Pisa, P. Pisa, H. Hang and R.I. Fox (1991) High frequency of t(14;18) translocation in salivary gland lymphomas from Sjögren's syndrome patients. J. Exp. Med. 174 1245-1250.
84. M. Polihronis, N.I. Tapinos, S.E. Theocharis, A. Economou, C. Kittas and H.M. Moutsopoulos (1998) Modes of epithelial cell death and repair in Sjögren's syndrome (SS). Clin. Exp. Immunol. 114 485-490.
85. E.J. Price, S.M. Brooks, W.S. Shattles and P.J.W. Venables (1994) Antibodies to Ro and La in the salivary pathology of Sjögren's syndrome. M. Homma, S. Sugai, T. Tojo, N. Miyakaka, M. Akizuki (Eds) Sjögren's Syndrome. State of the Art Amsterdam: Kugler 157-160.
86. M. Ramos-Casals, M. Garcia-Carrasco, M.P. Brito Zeron, R. Cervera and J. Font (2002) Viral etiopathogenesis of Sjögren's syndrome: role of the hepatitis C virus. Autoimmun. Rev. 1 238-243.
87. J.D. Reveille, M.J. Macleod, K. Whittington and F.C. Arnett (1991) Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro(SSA)/La(SSB) autoantibody responses. J. Immunol. 146 3871-3875.
88. A. Rosen, L. Casciola-Rosen and J. Ahearn (1995) Novel packages of viral and selfantigens are generated during apoptosis. J. Exp. Meet. 181 1557-1561.
89. J.G. Routsias, E. Touloupi, E. Dotsika, A. Moulia, V. Tsikaris, C. Sakarellos, M. Sakarellos-Daitsiotis, H.M. Moutsopoulos and A.G. Tzioufas (2002) Unmasking the anti-La/SSB response in sera, from patients with Sjögren's syndrome by specific blocking of antiidiotypic antibodies to La/SSB antigenic determinants. Mol. Med. 8 293-305.
90. J. Saegusa, A. Yasuda, H. Kubota and T. Ito (1994) Spontaneous sialoadenitis in IQI/JCL mice. A new animal model of primary Sjögren's syndrome. M. Homma, S. Sugai, T. Tojo, N. Miyakaka, M. Akizuki (Eds) Sjögren's Syndrome. State of the Art Amsterdam: Kugler 559-561.
91. S. Salomonsson, M.V. Jonsson, K. Skarstein, K.A. Brokstad, P. Hjelmstrom, M. Wahren-Herlenius and R. Jonsson (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 48 3187-3201.
92. F.N. Skopouli, P.C. Fox, V. Galanopoulou, J.C. Atkinson, E.C. Jaffe and H.M. Moutsopoulos (1991) T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J. Rheumatol. 18 210-214.
93. F.N. Skopouli, E. Kousvelari, P. Mertz, E.S. Jaffe, P.C. Fox and H.M. Moutsopoulos (1992) C-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome. J. Rheumatol. 19 693-699.
94. F.N. Skopouli, U. Dafni, J.P. Ioannidis, et al. (2000) Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin. Arthritis Rheum. 29 296-304.
95. F.N. Skopouli, N. Talal, V. Galanopoulou, C.G. Tsampoulas, A.A. Drosos and H.M. Moutsopoulos (1990) Raynaud's phenomenon in primary Sjögren's syndrome. J. Rheumatol. 17 618-620.
96. R.L. Slobbe, G.J.M. Pruijn and W.J. Van Venrooij (1991) Ro(SSA) and La(SSB) ribonucleoprotein complexes: Structure, function and antigenicity. Ann. Med. Interne 142 592-600.
97. F.C. Soliotis, C.P. Mavragani and H.M. Moutsopoulos (2004) Central nervous system involvement in Sjögren's syndrome. Ann. Rheum. Dis. 63 616-620.
98. E.W. St. Clair (1992) Anti-La antibodies. Rheum. Dis. Din. N. Am. 18 359-377.
99. E.W. St. Clair, J.C. Angellilo and K.H. Signer (1992) Expression of cell adhesion molecules in the salivary gland microenviroment of Sjögren's syndrome. Arthritis Rheum. 35 62-66.
100. M. Stiller, W. Golder and E. Doring (2000) Primary and secondary Sjögren's syndrome in children—a comparative study. Clin. Oral Invest. 4 176-182.
101. E. Theander, R. Manthorpe and L.T.H. Jacobsson (2004) Mortality and causes of death in primary Sjögren's syndrome. A prospective cohort study. Arthritis Rheum. 50 1262-1269.
102. H. Trevino, E.B. Tsaianos and S. Schenker (1987) N. Talal, H.M. Moutsopoulos, S.S. Kassan (Eds) Sjögren's syndrome. Clinical and Immunolotical Aspects Gastrointestinal and hepatobiliary features in Sjögren's syndrome Berlin: Springer-Verlag 8895.
103. A. Triantafyllopoulou, N. Tapinos and H.M. Moutsopoulos (2004) Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum. 50 2897-2902.
104. S. Tsunawaki, S. Nakamura, Y. Ohyama, M. Sasaki, A. Ikebe-Hiroki, A. Hiraki, T. Kadena, E. Kawamura, W. Kumamaru, M. Shinohara and K. Shirasuna (2002) Possible function of salivary gland epithelial cells as non-professional antigen-presenting cells in the development of Sjögren's syndrome. J. Rheumatol. 29 1884-1896.
105. B. Tumiati, P. Casoli and A. Parmeggiani (1997) Hearing loss in Sjögren's syndrome. Ann. Intern. Med. 126 450-453.
106. A.G. Tzioufas, R. Wassmuth, U.G. Dafni, A. Guialis, H.J. Haga, D.A. Isenberg, R. Jonsson, J.R. Kalden, H. Kiener, C. Sakarellos, J.S. Smolen, N. Sutcliffe, C. Vitali, E. Yiannaki and H.M. Moutsopoulos (2002) Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study. Ann. Rheum. Dis. 61 398-404.
107. J.P. Van de Merwe, R. Kamerling, H.S. Arendsen, A.H. Mulder and H. Hooijkaas (1993) Sjögren's syndrome in patients with interstitial cystitis. J. Rheumatol. 20 962-966.
108. C. Vitali, S. Bombardieri, H.M. Moutsopoulos, G. Balestrieri, W. Bencivelli, R.M. Bernstein, K.B. Bjerrum, S. Braga, J. Coll and S. de Vita (1993) Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 36 340-347.
109. C. Vitali, S. Bombardieri and H.M. Moutsopoulos the European Study Group on Diagnostic Criteria for Sjögren's syndrome (1996) Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. Ann. Rheum. Dis. 55 116-121.
110. C. Vitali, S. Bombardieri, R. Jonsson, H.M. Moutsopoulos, E.L. Alexander, S.E. Carsons, T.E. Daniels, P.C. Fox, R.I. Fox, S.S. Kassan, S.R. Pillemer, N. Talal and M.H. Weisman the European Study Group on Classification Criteria for Sjögren's Syndrome (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61 554-558.
111. F.B. Vivino, I. Al-Hashimi, Z. Khan, F.G. LeVeque, P.L. Salisbury 3rd, T.K. Tran-Johnson, C.C. Muscoplat, M. Trivedi, B. Goldlust and S.C. Gallagher (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren's syndrome. Arch. Intern. Med. 159 174-181.
112. P.G. Vlachoyiannopoulos and H.M. Moutsopoulos (1997) Therapy in Sjögren's syndrome. L.B.A. Van de Putte, D.E. Furst, H.J. Williams, P.L.C.M. Van Riel (Eds) Therapy of Systemic Rheumatic Disorders New York: Marcel Dekker 615-628.
113. M. Voulgarelis, U.G. Dafni, D.A. Isenberg and H.M. Moutsopoulos (1999) Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum. 42 1765-1772.
114. S.A. Waterman, T.P. Gordon and M. Rischmueller (2000) Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum. 4 1647-1654.
115. S. Winer, I. Astsaturov, R. Cheung, H. Tsui, A. Song, R. Gaedigk, D. Winer, A. Sampson, C. McKerlie, A. Bookman and H.M. Dosch (2002) Primary Sjögren's syndrome and deficiency of ICA69. Lancet 360 1063-1069.
116. G. Xanthou, N.I. Tapinos, M. Polihronis, I.P. Nezis, L.H. Margaritis and H.M. Moutsopoulos (1999) CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin. Exp. Immunol. 118 154-163.
117. G. Xanthou, M. Polihronis, A.G. Tzioufas, S. Paikos, P. Sideras and H.M. Moutsopoulos (2001) “Lymphoid” chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients. Arthritis Rheum. 44 408-418.
118. D.I. Yannopoulos, S. Roncin, A. Lamour, Y.L. Pennec, H.M. Moutsopoulos and P. Youinou (1992) Conjunctival epithelial cells from patients with Sjögren's syndromeinappropriately express major histocompatibility complex molecules, La/SSB antigen and heat shock proteins. J. Clin. Immunol. 12 259-265.
119. M.M. Zandbelt, J. Vogelzangs, L.B. Van De Putte, W.J. Van Venrooij and F.H. Van Den Hoogen (2004) Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome. Arthritis Res. Ther. 6 R33-R38.